News Releases
-
Exploring the Physical World
Ancient Hominins Used Fire to Make Stone Tools
REHOVOT, ISRAEL—October 5, 2020—Our ancestors not only knew how to use fire, they also developed sophisticated technologies for making tools. Researchers at the Weizmann Institute of Science recently employed cutting-edge technologies of their own to take a fresh look at a collection of stone tools.
-
Improving Health & Medicine
Repeated Pregnancy Loss May Be Tied to the Olfactory System
REHOVOT, ISRAEL—September 29, 2020—The odors we give off are a sort of body language – one that may affect our relationships more than we realize. New research from the lab of Prof. Noam Sobel at the Weizmann Institute of Science suggests that this “chemical communication” may extend to human reproduction as well.
-
Coronavirus
Bacteria Could Provide Us With the Next Antivirals
REHOVOT, ISRAEL—September 16, 2020—By tracking the evolution of what may be our oldest means of fighting off viral infection, a group at the Weizmann Institute of Science has uncovered a gold mine of antiviral substances that may lead to the development of highly effective antiviral drugs.
-
Culture & Community
The Weizmann Institute of Science and Mohamed bin Zayed University in the UAE to Collaborate on Artificial Intelligence Research
REHOVOT, ISRAEL—September 13, 2020—A Memorandum of Understanding (MoU) between the Weizmann Institute of Science in Israel and the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) in the United Arab Emirates was signed on September 12.
-
Coronavirus
Profiling the COVID-19 Coronavirus
REHOVOT, ISRAEL—September 9, 2020—“Contact tracing” inside infected cells is providing new clues into the workings of SARS-CoV-2, the virus that causes COVID-19. A research team at the Weizmann Institute of Science and the Israel Institute for Biological Research...
-
Enriching Education
The Weizmann Institute of Science is Offering Emergency Fellowships for Israeli Postdocs Affected by COVID-19
REHOVOT, ISRAEL—August 20, 2020—The Weizmann Institute of Science has initiated an emergency program to award grants to postdoctoral fellows whose research has been curtailed by restrictions imposed due to the coronavirus outbreak. The plan is to assist those who have completed doctorates in Israel and now must postpone their postdoctoral research abroad, as well as those who have begun postdocs abroad but have to return to Israel prematurely.
-
Improving Health & Medicine
Targeting a Chronic Pain Gateway Could Bring Relief
REHOVOT, ISRAEL—August 14, 2020—Something like a quarter of the world’s population suffers from chronic pain at some point. As opposed to acute pain – for example, that feeling after hitting your finger with a hammer – chronic pain may not even have a clear cause, and it can linger for years or lifetimes.
-
Improving Health & Medicine
Internal Differences: A New Method for Seeing Into Cells
REHOVOT, ISRAEL—August 10, 2020—Invading cells’ private space – prying into their internal functions, decisions, and communications – could be a powerful tool that may help researchers develop new immunotherapy treatments for cancer.
-
Culture & Community
Weizmann Institute of Science and Schneider Children’s Medical Center of Clalit Health Services to Collaborate
REHOVOT, ISRAEL—July 29, 2020—The Weizmann Institute of Science and Schneider Children’s Medical Center of Clalit Health Services signed a Memorandum of Understanding today on a collaborative biomedical research initiative. The “Schneider-Weizmann Center for Research on Child and Adolescent Health” will be jointly established by the two entities.
-
Advancing Technology
Artificial Cells Produce Parts of Viruses for Safe Studies
REHOVOT, ISRAEL—July 20, 2020—Scientists searching for better diagnostic tests, drugs, or vaccines against a virus must begin by deciphering the structure of that virus. And when the virus in question is highly pathogenic, such research can be quite dangerous.
-
Fighting Cancer
A New Approach to Tailoring Cancer Therapy: Tapping Into Signaling Activities in Cancer Cells
REHOVOT, ISRAEL—July 16, 2020—Choosing the right drug for each cancer patient is key to successful treatment, but physicians currently have few reliable pointers to guide them in designing treatment protocols. Researchers at the Weizmann Institute of Science and the Broad Institute of MIT and Harvard have now developed a new method...
-
Exploring the Physical World
The Magnetic History of Ice
REHOVOT, ISRAEL—June 29, 2020—The history of our planet has been written, among other things, in the periodic reversal of its magnetic poles. Researchers at the Weizmann Institute of Science propose a new means of reading this historic record: in ice.
-
Culture & Community
American Committee for the Weizmann Institute of Science Appoints James Konschnik Executive Director, Florida Region
FT. LAUDERDALE, FL—June 25, 2020—The American Committee for the Weizmann Institute of Science announced that James Konschnik, CFRE, has been appointed Executive Director of its Florida Region.
-
Culture & Community
American Committee for the Weizmann Institute of Science Appoints Dane Riggs Executive Director, Southwest Region
NEW YORK, NY—June 25, 2020—The American Committee for the Weizmann Institute of Science announced that Dane Riggs of Norman, OK, has been appointed Executive Director of its Southwest Region, comprising Texas, Arizona, Colorado, Nevada, New Mexico, and Utah.
-
Exploring the Physical World
Which Came First?
REHOVOT, ISRAEL—June 22, 2020—What did the very first proteins – those that appeared on Earth around 3.7 billion years ago – look like? Prof. Dan Tawfik of the Weizmann Institute of Science and Prof. Norman Metanis of the Hebrew University of Jerusalem have reconstructed protein sequences that may well resemble those ancestors of modern proteins...
-
Culture & Community
Weizmann Institute of Science is Seventh in Receiving Top European Research Commission Grants
REHOVOT, ISRAEL—June 22, 2020—The Weizmann Institute of Science is ranked seventh in Europe – and first in Israel – for the total number of research grants received from the European Research Council (ERC) for the years 2007-2019.
